Research in Medical and Dental Sciences We are dedicated to performing world-leading research with the ultimate goal of improving human health.
Cancer and Genomics Experimental cancer therapy research continues at Birmingham New and innovative ways to detect and treat cancer being trialled at Birmingham are to receive renewed funding from Cancer Research UK and the NIHR.
03 February 2023 Immunocompromised patients remain at higher risk of COVID-19 death in hospital Patients had 44% higher risk of death in hospital compared to those with healthy immune system function
19 January 2023 Chemotherapy before surgery cuts risk of colon cancer returning, trial finds Patients with early stage colon cancer benefit from 6 weeks of chemotherapy before surgery
16 January 2023 Experimental cancer therapy research continues at Birmingham New and innovative ways to detect and treat cancer being trialled at Birmingham are to receive renewed funding from Cancer Research UK and the NIHR.
04 January 2023 Protein anchors found to play key role in neurotransmitter GABA action Discovery could lead to new therapies for neurological disorders such as Multiple Sclerosis
12 December 2022 Heart surgery and impact on mental health among new priorities for congenital heart disease research Patients, parents, charities and healthcare professionals agree key focuses for future research for disease affecting around half a million in UK
08 December 2022 Babies born to Black mothers in rich countries twice as likely to die in first weeks of life Largest analysis of perinatal outcomes finds disparities in outcomes based on race and ethnicity in high and upper-middle income countries
08 December 2022 MDS colleagues celebrate receiving MRC clinical fellowships Two University of Birmingham researchers have been awarded prestigious Medical Research Council (MRC) clinical fellowships this year.
01 December 2022 Immune T cell defence is coping with COVID-19 variants of concern – for now Broad T-cell response is currently protective but recognition of seven out of ten T-cell targets mutated in SARS-CoV-2 variants is impaired
23 November 2022 World’s first clinical trial to test new drug glenzocimab for heart attacks New partnership with Acticor Biotech will see patients with heart attacks treated with glenzocimab, a promising new class of drug for the first time.
21 November 2022 ‘Playbook’ sets out ways to fight back against antimicrobial resistance ‘Resistance breakers’ and better genetic tests are among new ways that scientists could address antimicrobial resistance, a new paper suggests.
16 November 2022 Inflammation and Ageing Research Fellow receives £1.2M Competitive MRC Career Development Fellowship Dr Jon Hazeldine, Research Fellow at the University of Birmingham, has been awarded a competitive MRC Career Development Award Fellowship totalling £1.2M.
15 November 2022 Researchers make miniature ‘bone marrows in a dish’ to improve anti-cancer treatments The organoids provide a micro-environment that can accept and support the survival of cells from patients with blood malignancies